|
|
 |
|
Total Number of Holdings (excluding cash): 50
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
973 |
$77,402.15 |
2.33% |
| Alcon Inc. |
ALC.SW |
H01301128 |
1,001 |
$74,112.55 |
2.23% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
592 |
$72,909.33 |
2.20% |
| Insulet Corporation |
PODD |
45784P101 |
473 |
$72,657.53 |
2.19% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
2,623 |
$72,426.58 |
2.18% |
| The Cooper Companies, Inc. |
COO |
216648501 |
1,176 |
$72,088.80 |
2.17% |
| Medtronic Plc |
MDT |
G5960L103 |
723 |
$71,786.67 |
2.16% |
| Teleflex Incorporated |
TFX |
879369106 |
511 |
$71,882.37 |
2.16% |
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
175 |
$71,379.00 |
2.15% |
| Cochlear Limited |
COH.AU |
Q25953102 |
714 |
$71,105.40 |
2.14% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
1,460 |
$71,076.43 |
2.14% |
| Abbott Laboratories |
ABT |
002824100 |
642 |
$70,722.72 |
2.13% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
980 |
$70,608.83 |
2.13% |
| Stryker Corporation |
SYK |
863667101 |
231 |
$70,873.11 |
2.13% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
4,739 |
$70,527.38 |
2.12% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
751 |
$70,038.26 |
2.11% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
201 |
$70,219.30 |
2.11% |
| BioMerieux |
BIM.FP |
F1149Y232 |
687 |
$69,906.24 |
2.10% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
718 |
$69,897.30 |
2.10% |
| Steris Plc |
STE |
G8473T100 |
298 |
$69,538.30 |
2.09% |
| Align Technology, Inc. |
ALGN |
016255101 |
448 |
$69,050.24 |
2.08% |
| Becton, Dickinson and Company |
BDX |
075887109 |
348 |
$69,112.80 |
2.08% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,251 |
$69,179.02 |
2.08% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
1,762 |
$68,697.86 |
2.07% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
41 |
$68,805.79 |
2.07% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
857 |
$68,097.22 |
2.05% |
| Terumo Corporation |
4543.JP |
J83173104 |
4,460 |
$67,698.50 |
2.04% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
268 |
$67,289.37 |
2.03% |
| LivaNova Plc |
LIVN |
G5509L101 |
837 |
$67,135.77 |
2.02% |
| Boston Scientific Corporation |
BSX |
101137107 |
1,497 |
$66,347.04 |
2.00% |
| Danaher Corporation |
DHR |
235851102 |
291 |
$66,339.27 |
2.00% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
5,434 |
$66,574.95 |
2.00% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
151 |
$65,967.37 |
1.99% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
97 |
$66,217.05 |
1.99% |
| Waters Corporation |
WAT |
941848103 |
147 |
$66,080.91 |
1.99% |
| ResMed Inc. |
RMD |
761152107 |
278 |
$64,757.32 |
1.95% |
| Agilent Technologies, Inc. |
A |
00846U101 |
375 |
$64,496.25 |
1.94% |
| DexCom, Inc. |
DXCM |
252131107 |
760 |
$64,417.60 |
1.94% |
| LeMaitre Vascular, Inc. |
LMAT |
525558201 |
793 |
$64,439.18 |
1.94% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
175 |
$64,078.00 |
1.93% |
| Penumbra, Inc. |
PEN |
70975L107 |
200 |
$64,268.00 |
1.93% |
| Baxter International Inc. |
BAX |
071813109 |
2,627 |
$63,625.94 |
1.92% |
| Revvity, Inc. |
RVTY |
714046109 |
415 |
$62,914.00 |
1.89% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
2,392 |
$61,793.59 |
1.86% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
733 |
$61,799.23 |
1.86% |
| Hoya Corporation |
7741.JP |
J22848105 |
394 |
$61,443.94 |
1.85% |
| Olympus Corporation |
7733.JP |
J61240107 |
5,040 |
$55,370.86 |
1.67% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
2,377 |
$54,907.24 |
1.65% |
| Shanghai Microport Medbot (Group) Co., Ltd. (Class H) |
2252.HK |
Y768JD106 |
16,500 |
$44,537.76 |
1.34% |
| US Dollar |
$USD |
|
24,483 |
$24,482.67 |
0.74% |
| Japanese Yen |
$JPY |
|
42,336 |
$268.05 |
0.01% |
| Euro |
$EUR |
|
0 |
$0.06 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.15 |
0.00% |
| TPG Inc. (CVR) |
2602335D |
436CVR021 |
612 |
$0.00 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|